Henry Ford Health System

Henry Ford Health System Scholarly Commons
Orthopaedics Articles

Orthopaedics / Bone and Joint Center

9-1-2020

Arthroplasty during the COVID-19 Pandemic
Trevor North
Henry Ford Health System, tnorth1@hfhs.org

Matthew W. Bullock
Jonathan R. Danoff
Arjun Saxena
Stuart J. Fischer

See next page for additional authors

Follow this and additional works at: https://scholarlycommons.henryford.com/orthopaedics_articles

Recommended Citation
North T, Bullock MW, Danoff JR, Saxena A, Fischer SJ, Stronach BM, Levine BR. Arthroplasty during the
COVID-19 Pandemic. Arthroplast Today 2020; 6(3):427-430.

This Article is brought to you for free and open access by the Orthopaedics / Bone and Joint Center at Henry Ford
Health System Scholarly Commons. It has been accepted for inclusion in Orthopaedics Articles by an authorized
administrator of Henry Ford Health System Scholarly Commons.

Authors
Trevor North, Matthew W. Bullock, Jonathan R. Danoff, Arjun Saxena, Stuart J. Fischer, Ben M. Stronach,
and Brett R. Levine

This article is available at Henry Ford Health System Scholarly Commons: https://scholarlycommons.henryford.com/
orthopaedics_articles/254

Arthroplasty Today 6 (2020) 427e430

Contents lists available at ScienceDirect

Arthroplasty Today
journal homepage: http://www.arthroplastytoday.org/

White Paper

Arthroplasty during the COVID-19 Pandemic
Trevor North, MD a, Matthew W. Bullock, DO, MPT b, *, Jonathan R. Danoff, MD c,
Arjun Saxena, MD, MBA d, Stuart J. Fischer, MD e, Ben M. Stronach, MD f,
Brett R. Levine, MD, MS g
a

Henry Ford Health System, Detroit, MI, USA
Department of Orthopaedic Surgery, Marshall University Joan C. Edwards School of Medicine, Huntington, WV, USA
c
Department of Orthopaedic Surgery, Northwell Health Orthopaedic Institute, Great Neck, NY, USA
d
Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Philadelphia, PA, USA
e
Summit Orthopaedics and Sports Medicine, Summit, NJ, USA
f
Department of Orthopaedic Surgery, University of Mississippi Medical Center, Jackson, MS, USA
g
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
b

a r t i c l e i n f o

a b s t r a c t

Article history:
Received 24 April 2020
Received in revised form
30 April 2020
Accepted 5 May 2020
Available online 19 May 2020

This article aims to give a brief outline of the pathogenesis and transmission of SARS-CoV-2 and how to
safely navigate an arthroplasty practice during and after the pandemic.
© 2020 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/lice
nses/by-nc-nd/4.0/).
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Introduction
The coronavirus disease (COVID-19) caused by the SARS coronavirus 2 (SARS-CoV-2) has brought professional life to a standstill for
many orthopaedic surgeons around the world. Although some will be
given roles to work on the front lines or take on leadership positions
during this crisis, many surgeons will act in a supportive or reserve
role. This article aims to give a brief outline of the pathogenesis and
transmission of SARS-CoV-2 and how to safely navigate your practice
during and after the pandemic. We will outline recommendations of
how to resume clinical operations when restrictions are lifted.

presents [1]. Early presenting symptoms of the virus frequently
include fever, nonproductive cough, and fatigue, and occasionally
gastrointestinal symptoms and anosmia [2-4]. A well-characterized
subset of the population contracts the infection with indiscernible
symptoms. The average incubation period has been reported to last
14 days, with a median presentation of 5 days [5,6]. There have
been some reports of patients remaining infectious for over 20 days
from the symptom onset [5]. Without widespread testing, quantiﬁcation of this asymptomatic group in the pandemic is nearly
impossible to determine [6].
Basic pathogenesis

Presentation and incubation
As of writing of this article, there are over 3 million COVID19epositive cases globally with over 215,000 deaths; however, the
true number of cases has been and will continue to be difﬁcult to
ascertain because of the varying nature of how the viral illness
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Infection begins when the virus binds to target human epithelial
cells through the intermediary enzyme angiotensin-converting
enzyme 2 [7]. It is believed that the upregulation of angiotensinconverting enzyme 2 during infection combined with
angiotensin-converting enzyme inhibitors, angiotensin receptor
blockers, nonsteroidal anti-inﬂammatory drugs, or thiazolidinediones can potentially predispose patients to a myriad of complications, including cardiac arrest, impaired ventilation, and death
[7]. In addition, current research has found increased mortality in
patients with multiple comorbidities including older age, obesity,
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existing pulmonary diagnoses, and diabetes [6-8]. In addition, hypertension may also be associated with an increased risk of both
contracting symptomatic COVID-19 and hospitalization [7].
Currently, patients contracting the virus have a mortality rate between 4% and 7%, which is nearly 4 times that of the inﬂuenza virus
[2,4]. This close-contact disease is spread via respiratory droplets
that can enter the respiratory tract via mucosae or conjunctiva
[8,9]. Transmission can also occur through fomites within the immediate environment of an infected person [8].
Therapies
At this time, there is no proven or accepted treatment for patients with COVID-19. Current management strategies for ~80% of
cases include symptomatic treatment focused on hydration and
fever control (antipyretics) [2]. Intensive care monitoring and
ventilator support are reserved for severe cases. The current trend
is to review the efﬁcacy of available therapeutic drugs in hopes of
improving outcomes for patients with COVID-19. Multiple agents
are currently being investigated, but none presently have yet been
shown to offer a reliable beneﬁt for patients.
Premature studies have suggested hydroxychloroquine, best
known for its role in malaria prophylaxis and rheumatoid arthritis
maintenance therapy, and remdesivir, an antiviral that gained
popularity during the Ebola epidemic, could be effective in managing COVID-19 [10-12]. While no current randomized controlled
trials exist, both medications are currently being investigated in
several large clinical trials. Meanwhile, plasma infusion therapy
using the separated blood products containing antibodies against
COVID-19 from patients who have recovered is a strategy reserved
for the most serious of cases [13]. Several vaccine trials are on the
horizon with hopes of mass production within the next 12-18
months to promote long-term immunity, but further research is
still required.
Ofﬁce practice
Surgeons may selectively evaluate patients in the ofﬁce during
the pandemic. New patients and follow-ups are being asked to
reschedule to help limit exposure. Most ofﬁces see only patients
with time-sensitive conditions including new fractures, suspected
infection, or neurovascular compromise [14]. All patients should be
screened before entering the ofﬁce for fever, chills, or cough. If
positive, they should be issued a mask and sent directly for evaluation per local protocol. The Centers for Disease Control and Prevention (CDC) currently recommends all individuals wear a simple
mask when in public and to limit touching their face to prevent
viral transmission [13]. The mask should cover the nose and mouth
to prevent a contagion from infecting others with a compromised
immune system. The CDC currently recommends an N95 mask be
used for known COVID-19epositive patients [3,13]. Social
distancing, which is currently deﬁned as maintaining a distance of
6 feet from others, should continue among staff and patients.
Rearranging waiting room seats, limiting the number of patients,
coordinating radiograph time slots, and terminal cleaning of all
essential equipment are required to comply with social distancing
regulations set forth by the CDC to help prevent the spread of the
virus [13].
Personal protective equipment (PPE) supply and stewardship
will be important for the foreseeable future as reserves will likely
remain low for some time in some areas. The proper removal and
disposal of PPE should be reviewed to prevent inadvertent
contamination [13]. Local guidance for use of PPE should be followed. Routine virucidal decontamination of reusable medical
equipment/supplies should take place between each patient use.

As restrictions are gradually lifted, strict hand hygiene and social
distancing will remain important in the ofﬁce and community. The
CDC recommends washing hands with soap and water whenever
possible, and if unavailable, then using a hand sanitizer with at least
60% alcohol is encouraged [13,15]. A list of the CDC-approved sanitizers can be found on CDC’s website [15].
Stafﬁng
Orthopaedic practices will need to prepare for potential exposure of a staff member or colleague. When symptoms consistent
with COVID-19 infection are suspected or testing is positive for the
virus, the individual should be sent home immediately and plan to
quarantine until symptoms resolve [3,13]. Hospital infectious disease specialists have outlined viral testing protocols that can vary
among facilities; therefore, we encourage surgeons to check with
their afﬁliated hospital. Current return-to-work standards as outlined by the CDC include [13] the following:
1. Absence of fever without the use of antipyretic medications.
2. No dyspnea at rest.
3. Two independent, negative COVID-19 assays at least 24 hours
apart.
As a prophylactic measure, staff members with risk factors for
contracting the virus should be encouraged to work remotely from
home if possible. The recommendations are frequently updated
from the CDC [13].
Integration of telemedicine
Virtual platforms offer an alternative to traditional in-ofﬁce
patient visits, given social distancing restrictions. In addition,
these visits are billable encounters and represent an existing opportunity to maintain some degree of revenue-generating productivity. These include real-time audio-visual telemedicine visits,
audio-alone telephone visits, and e-visits using patient portals.
There are a number of regulatory and compliance matters speciﬁc
to virtual health care at the federal and state levels, as well as payerspeciﬁc rules [16,17]. Providers should be familiar with these before
initiating such modalities. Of note, there have been recent relaxations aimed at encouraging virtual health care at the federal
level and state level and among payers. Many of these are temporary and tied to the pandemic, including those from the Department of Health and Human Services [16,18]. Given the evolving
climate, ofﬁces should maintain a source document and log concerning compliance and remain vigilant for changes [16].
Codes for ofﬁce telemedicine visits are 99201-99215 for new
and established patients and require real-time audio and video
[16]. Billing can be determined by medical decision-making (using
1995/1997 guidelines) or total provider time on the day of service,
including preparation, and should append a 95 Modiﬁer to comply
with the recommended billing practices [16]. The Centers for
Medicare and Medicaid services has also provided relaxed telemedicine regulations around a number of other visit types,
including hospital-based and emergency departmentebased codes
[16,17]. If your practice does not use a major third-party electronic
health record (EHR) vendor with a Health Insurance Portability and
Accountability Actecompliant option for video-based telemedicine, video-conferencing applications such as Facetime, Doxy.me,
and Zoom are readily available. Enforcement discretion has been
announced for Health Insurance Portability and Accountability Act
compliance in connection with telehealth care during the COVID-19
emergency, but providers should avoid public-facing platforms
such as Facebook Live. Providers are encouraged to monitor
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ongoing regulation changes as conditions are expected to be reevaluated soon [16].
Telemedicine visits can be completed via the smartphone,
tablet, or computer. Audio-only visits for those patients who are
unable to access audiovisual platforms are an acceptable form, and
some payers allow for use of 99201-99215; however, Medicare will
not [16]. Appropriate evaluation/management codes for audio-only
visits are 99441-99443 and depending on the amount of time spent
on the telehealth consult with the patient [16,17]. Relative value
unit values for these codes are less than the telemedicine codes.
Appropriate patient evaluation, documentation, and coding of
these telemedicine visits can be reviewed in the American Association of Hip and Knee Surgeons WebinardTelemedicine and Total
Joint Surgeons: How to Run a Virtual Practice (https://aahkszoom.
s3.amazonaws.com/Telemedicine/webinar-telemedicine04142020.mp4).
Operative cases
Elective arthroplasty cases have been postponed at most hospitals around the country; however, many surgeons continue to
contribute through on-call responsibilities and addressing timesensitive urgent and emergent cases [14]. The operating room can
be a high-risk environment during the current pandemic, particularly if intubation is required, as the virus can become aerosolized.
Most of these recommendations have been learned from prior
experience with aerosolization of SARS-CoV-2 [2,4,5]. The COVID
virus has not been isolated in the bone or marrow, which is
particularly relevant to orthopaedic surgeons using high-speed
burs and saws [12,19]. To further protect trainees, the Accreditation Council for Graduate Medical Education has recommended
medical students, residents, fellows, and other support staff
members should only be used in the operating room if absolutely
necessary to prevent viral exposure [20].
All team members should don an approved gown, gloves, eye
protection, and an N95 mask before contact with an active COVID19 patient [19]. It is currently recommended that only essential
members of the anesthesia team are present in the operating suite
at the time of intubation. To prevent potential exposure, the surgical team should enter the operative suite only after the airway is
secured and an allotted amount of time to allow air exchange
within the operative environment. Most air-handling systems can
exchange the air in 15 minutes, but this should be conﬁrmed with
your hospital’s engineering department [21]. Surgeons should
consult their anesthesia colleagues in regard to general or regional
anesthesia for infected patients.
It is important to remain vigilant during this time of increased
infectivity, especially in high-risk environments such as the operating room and intensive care unit (ICU). According to manufacturers, orthopaedic surgical hoods alone are not protective against
this virus [13,19]. All surgeons and operative staff members should
maintain universal precautions at all times and use N95 masks
when operating on COVID-19esuspected or COVID-19econﬁrmed
patients [3,13,20]. Covering the N95 with a level 1 approved mask
may help to prevent soilage, which then requires mask disposal
[13,19]. Otherwise, the N95 mask can be decontaminated by a variety of methods and then reused.
As mentioned previously, there are subsets of population that
have increased risk of morbidity and mortality with COVID-19 disease [2-6]. Patients who undergo surgery during active infection or
become infected shortly after surgery are another identiﬁed highrisk population [4,22]. A recent retrospective cohort study from
China summarized their early operative outcomes on this population [22]. Their ﬁndings are consistent with current thoughts, suggesting that older individuals with multiple comorbidities are at
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higher risk of complications. Surgery on these patients, such as a
high-energy trauma patient, seems to initiate a “second-hit” phenomenon that can induce a systemic inﬂammatory response.
Operating on a patient with COVID-19 can have grave consequences,
with nearly 44% requiring ICU care after surgery and a mortality rate
up to 20% [22]. As surgeons, we will need to maintain open
communication between the other members of the medical team to
provide coordinated care for our patients. The ability to consistently
and promptly identify SARS-CoV-2 carriers will further help to
navigate this pandemic. Routine serologic testing for SARS-CoV-2
for all patients, and in some circumstances, health-care staff members, is being considered by public health ofﬁcials.
A return to normal
A timeframe for a normal elective arthroplasty schedule is still
being debated. Initially, there will need to be a balance between
surgical volume to address case backlogs and ensuring orchestration of appropriate hospital support for patients regarding staff and
supplies. In addition, availability of the operating room PPE and a
reliable central processing system are keys to operative consistency. Regular open communication with immediate team members, nursing managers, and hospital administrators will facilitate a
safe return to elective cases.
The surgeon also needs to facilitate discussions between device
manufacturers and hospitals to ensure essential equipment is available. This is of particular importance because many supply chains
have been disrupted; implant companies may need additional time to
ensure equipment and implants are readily available. During the early
return to elective cases, surgeons must remain ﬂexible with operative
schedules, knowing that case mix may vary for an extended period of
time in comparison with previous practice routine.
Social distancing practices will likely persist for quite some time
after elective cases resume. Patient social support systems will be
impacted as we expect most facilities will limit visitors at ofﬁce
encounters and around the perioperative period for an underdetermined period of time as we continue to navigate the viral
pandemic. Surgeons should be prepared for the possibility that a
patient’s family member or support person may not be allowed to
enter the facility and their comfort level without a “coach” may lead
to delay or cancellation of the surgery. These considerations will
likely impact the surgeon’s normal schedule. Reopening schedules
for elective cases will likely include some additional challenges.
Concurrently, multiple outpatient therapy clinics, considered
essential businesses, remain open to provide rehabilitation services
during the pandemic [23]. The opportunities for manual interventions will be limited; therefore, the therapist will consider
transitioning to a coach/instructor over therapy-speciﬁc telehealth
venues (ie, Force Therapeutics, VERA by Reﬂection Health, and
Virtual Physical Therapy) to continue to assess range-of-motion
and regain function during this period [23].
Operating room efﬁciency will most likely be affected because of
room turnover precautions. This is in part due to the extra time
required for cleaning and preparation protocols including proper
room sterilization procedures, air ﬁltering protocols after intubation, and limited availability of support personnel. Furthermore, the
patient volume and postanesthesia care unit throughput will also
be a hindrance as the ramp-up initiates.
At the start, joint replacement surgeons may want to focus on
routine primary cases and gradually introduce more complex cases
over the next several months. Some entities have suggested that highvolume revision cases may place undue strain on PPE supplies,
operating equipment sterilization, and staff social distancing practices. Complex cases will likely require lengthy hospital stays, which
increases the risk of patient exposure to the virus [23]. In addition,
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larger cases carry a higher likelihood of ICU admission in a time when
acute care beds and ventilators are in short supply. Surgeons are
advised to check with their individual hospitals for guidance on these
issues.
Finally, procedures and regulations will vary across different
regions of the country and community settings. Areas with lower
viral density are more likely to see a faster “return to normal” than
harder hit regions. By the same token, hospitals and surgery centers
in smaller cities that are more remote from larger urban areas may
be faster to ramp up their elective schedules.
An evolution in health care is on us as we learn to navigate this
pandemic. Expect the time to resume normal schedules and procedures to be gradual over the next several months. Advances in
telecommunication enable surgeons and therapists an avenue to
provide individualized patient care from a safe distance. Above all,
communication remains essential to meet patient needs and expectations. If a patient requires a face-to-face encounter, appropriate precautions have been outlined to ensure the ofﬁce visit is
safe for all parties involved. Because this respiratory disease is
spread via droplet transmission, hand hygiene is the most critical
step to slow the spread of the COVID-19 virus. Patience is paramount as we adapt our orthopaedic practices to safely meet the
future needs of our patients.
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